VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Clinical trial NCT02294565 · UNKNOWN
Trial details
- NCT number
- NCT02294565
- Sponsor
- Vestan, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.